Investor's Business Daily on MSN6d
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedDexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...
The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dexcom received a warning letter on ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
Zacks Investment Research on MSN3d
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
DexCom Inc. closed 50.22% short of its 52-week high of $142.00, which the company achieved on March 26th.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Citi raised the firm’s price target on DexCom (DXCM) to $104 from $101 and keeps a Buy rating on the shares. The firm adjusted medical ...
Investopedia on MSN7d
Top Stock Movers Now: Tesla, DexCom, Strategy, and MoreShares of DexCom (DXCM) sank after the manufacturer of glucose monitoring devices said it had received a warning letter from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback